These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4965584)

  • 21. Large-area burns with pandrug-resistant Pseudomonas aeruginosa infection and respiratory failure.
    Ning FG; Zhao XZ; Bian J; Zhang GA
    Chin Med J (Engl); 2011 Feb; 124(3):359-63. PubMed ID: 21362333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas hyperimmune globulin: antibiotic treatment of experimental Pseudomonas sepsis in burned mice.
    Holder IA; Neely AN
    Antibiot Chemother (1971); 1989; 42():109-23. PubMed ID: 2512833
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic effect of Kasugamycin on respiratory infections due to Pseudomonas aeruginosa].
    Hiro Y; Doi Y
    J Antibiot B; 1967 Apr; 20(2):85-9. PubMed ID: 5299330
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pseudomonas aeruginosa. A pathogenic microbe of current importance].
    Bergan T
    Tidsskr Nor Laegeforen; 1969 Jun; 89(12):1014-6. PubMed ID: 4979183
    [No Abstract]   [Full Text] [Related]  

  • 25. Bacteriological observations on carbenicillin in the control of Pseudomonas aeruginosa infection in burns.
    Van Rooyen CE; Ross JF; Bethune GW; MacDonald AC
    Can Med Assoc J; 1967 Nov; 97(20):1227-9. PubMed ID: 4964146
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental efficacy of apalcillin and cefpiramide compared with that of six other antipseudomonal agents in Pseudomonas aeruginosa burn infections.
    Fu KP; Vince T; Hung PP; Gregory JF
    Drugs Exp Clin Res; 1986; 12(4):303-6. PubMed ID: 3720518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
    Drake DJ; Froese EH
    Cent Afr J Med; 1975 Apr; 21(4):71-2. PubMed ID: 806345
    [No Abstract]   [Full Text] [Related]  

  • 28. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF; Kharitonova AM; Chanturiia TsK
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of gentamicin, tobramycin and their combinations with prodigiozan in an experimental infection caused by Pseudomonas aeruginosa].
    Shcherbakova EG; Medvedeva MM; Rastunova GA; Sobolev VR
    Antibiotiki; 1975; 20(12):1112-5. PubMed ID: 817650
    [No Abstract]   [Full Text] [Related]  

  • 30. A burned mouse model to evaluate anti-Pseudomonas activity of topical agents.
    Stieritz DD; Bondi A; McDermott D; Michaels ED
    J Antimicrob Chemother; 1982 Feb; 9(2):133-40. PubMed ID: 6801006
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical use of Kasugamycin for urinary tract infections due to Pseudomonas aeruginosa].
    Ishigami J; Fukuda Y; Hara S
    J Antibiot B; 1967 Apr; 20(2):83-4. PubMed ID: 5299159
    [No Abstract]   [Full Text] [Related]  

  • 32. Pseudomonas aeruginosa infection in burn patients in Sulaimaniyah, Iraq: risk factors and antibiotic resistance rates.
    Othman N; Babakir-Mina M; Noori CK; Rashid PY
    J Infect Dev Ctries; 2014 Nov; 8(11):1498-502. PubMed ID: 25390066
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa.
    Toama MA; Hamed IM; Ashour SM
    Pharmazie; 1980; 35(4):228-30. PubMed ID: 6773076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bacteriological studies on a new antibiotic, Kasugamycin].
    Nakazawa S; Kanamori M; Ikunaga Y; Yamakawa N; Yoshida H
    J Antibiot B; 1967 Apr; 20(2):90-3. PubMed ID: 4964188
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pseudomonas aeruginosa burn wound infection in rats].
    Guo ZR
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1988 Mar; 4(1):51-3. PubMed ID: 3151321
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental study on topical antimicrobial agents in burns.
    Ge SD; Hu ZL; Cheng YL; Fang ZY; Tu SZ; Xu BR; Jiang XT
    Burns Incl Therm Inj; 1987 Aug; 13(4):277-80. PubMed ID: 3664316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Antibiotic Susceptibility of Pseudomonas aeruginosa Corneal Ulcer Isolates.
    Gupta S; Mittal S; Nayak N; Satpathy G; Khokhar S; Agarwal T
    Ocul Immunol Inflamm; 2015 Jun; 23(3):252-5. PubMed ID: 24564536
    [No Abstract]   [Full Text] [Related]  

  • 38. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract]   [Full Text] [Related]  

  • 39. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Coetzee E; Rode H; Kahn D
    S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
    Zellner PR; Zwissler O; Metzger E
    Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.